Companies / Elevance Health Inc
Elevance Health Inc
Financials · FY2025
Ownership
216.9M shares outstanding · as of Jul 10, 2026
Ownership
| Insiders | 0.17% | 375,252 |
| 10%+ / strategic | 7.65% | 16,601,224 |
| Institutions | 93.79% | 203,396,428 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 19
View all →| Insider | % of shares | Shares |
|---|---|---|
Boudreaux GailCEOPresident and CEO · Director | 0.08% | 169,251 |
Norwood Felicia FEVP &Chief Health Benefits Ofr | 0.02% | 38,838 |
Kaye MarkEVP & CFO | 0.01% | 32,037 |
Haytaian Peter DEVP & Pres Carelon & CarelonRx | 0.01% | 27,222 |
Lavu RatnakarEVP & Chief Digital Info Ofr | <0.01% | 16,149 |
Hay Lewis IIIDirector | <0.01% | 12,070 |
Kendrick Charles Morgan JREVP & President, Commercial | <0.01% | 11,791 |
Dixon Robert L JRDirector | <0.01% | 10,734 |
Peru Ramiro GDirector | <0.01% | 9,908 |
Wessling Erin MEVP & Chief Legal Officer | <0.01% | 7,579 |
Institutional holders 1,568
View all →| Holder | Value | % of shares |
|---|---|---|
| $8.07B | 10.61% | |
| $7.34B | 8.76% | |
| $4.03B | 4.81% | |
| $2.91B | 3.82% | |
| $2.02B | 2.65% | |
| $1.76B | 2.32% | |
| $1.68B | 2.21% | |
| $1.51B | 2.39% | |
| $1.37B | 1.80% | |
| $1.21B | 1.91% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Boudreaux Gail CEO | Other | Common Stock | $1.97M | -7K -4.45% | 144,307 0.07% of shares | low |
| Mar 6, 2026 | Kendrick Charles Morgan JR Executive | Sell | Common Stock | $910.6K | -3K -21.33% | 11,791 <0.01% of shares | medium |
| Mar 5, 2026 | Collis Steven H Director | Buy | Common Stock | $869.5K | +3K +469.48% | 3,639 <0.01% of shares | high |
| May 19, 2026 | Penczek Ronald W Executive | Sell | Common Stock | $617.2K | -2K -27.15% | 4,109 <0.01% of shares | medium |
| Mar 3, 2026 | Boudreaux Gail CEO | Other | Common Stock | $493.1K | -2K -1.02% | 169,251 0.08% of shares | low |
| Mar 2, 2026 | Norwood Felicia F Executive | Other | Common Stock | $417.9K | -1K -4.45% | 30,518 0.01% of shares | low |
| Mar 2, 2026 | Kendrick Charles Morgan JR Executive | Other | Common Stock | $356.1K | -1K -11.97% | 8,905 <0.01% of shares | low |
| Mar 2, 2026 | Haytaian Peter D Executive | Other | Common Stock | $353.2K | -1K -4.62% | 24,803 0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Capital Management | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ELV | — | 036752103 |